LB

Lidia A Brownell

VP Clinical Research And Regulatory Compliance at Unigen, Inc.

Lidia A Brownell has worked in various positions throughout their career. Lidia A started as the Director of Clinical Operations at Northwest Kinetics in 1998 and stayed in this role until 2004. Lidia A then joined Franciscan Health System as the Regional Technical Services Manager from 2004 to 2007. Lidia's next role was at Unigen, Inc. where they served as the Director of Clinical Research from 2007 to 2012, and later as the VP of Clinical Research and Regulatory Compliance from 2012 onwards.

Lidia A Brownell holds a Bachelor of Science in Medical Technology with a focus on Biology from Creighton University. Additionally, they have a Master's degree in Health Care Administration from Webster University.

Location

Tacoma, United States

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Unigen, Inc.

1 followers

From discovery to distribution, Unigen is dedicated to the development of botanical and marine-derived therapeutic compounds that address consumer health needs and improve quality of life. Established in 1996, our research and discovery process includes extensive testing at the genetic, cellular, and human clinical levels. Unigen is a global leader in the discovery and development of proprietary natural ingredients for the dietary supplement, food, cosmetics, personal care and pharmaceutical industries. With a core of scientifically substantiated natural ingredients already distribute worldwide, we continue to push the boundaries of pharmaceutical quality research and novel applications for natural products. The company has one of the most extensive medicinal plant collections in the world and utilizes a state-of-the-art pharmaceutical discovery approach to identify the most safe and effective botanically-based proprietary ingredients. The efficacy of Unigen’s natural product ingredients is established through human clinical trials, and unlike synthetic drugs, Unigen’s natural substances have a legacy of safe human consumption without the undesirable side-effects that limit the use of pharmaceuticals. Unigen protects its discoveries through patents and commercializes its products through alliances with partners that possess distribution and marketing capabilities in each of Unigen’s target markets.


Employees

51-200

Links